Adrenergic beta-1 Receptor Antagonists

All categories
DBCAT000458Pharmacologic class

Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. A DrugBank category of 10 drugs. 9 of them are approved.

Part of
Adrenergic beta-Antagonists
Also known as
Adrenergic beta 1 Antagonists · Adrenergic beta 1 Receptor Antagonists · Adrenergic beta 1 Receptor Blockers · Adrenergic beta-1 Antagonists · Adrenergic beta-1 Receptor Blockers
Drugs

What you can answer from here — as of March 12, 2021

10DrugsEach linked to its full drug card
Listed above
24Drug targetsEvery drug–target pair in the class, with bond type
Sign in
6,841Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
8Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Adrenergic beta-1 Receptor Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In